Home › Pulmonary Arterial Hypertension › Ohio › Cincinnati
Pulmonary Arterial Hypertension clinical trials in Cincinnati, OH
7 studies for Pulmonary Arterial Hypertension are looking for participants at sites in and around Cincinnati (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Study of REGN13335 in Adult Participants With Pulmonary Arterial Hypertension (PAH)
RecruitingPhase 2
- University of Cincinnati, Cincinnati
An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)
RecruitingPhase 3
- University of Cincinnati, Cincinnati
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
RecruitingObservational studyHealthy volunteers welcome
- Cincinnati Childrens Hospital Medical Center, Cincinnati
Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)
RecruitingPhase 3
- University of Cincinnati Medical Center, Cincinnati
Study to Evaluate Sotatercept (MK-7962) in Children With Pulmonary Arterial Hypertension (PAH) (MK-7962-008)
RecruitingPhase 2
- Cincinnati Children's Hospital Medical Center ( Site 1602), Cincinnati
Pulmonary Hypertension Association Registry
RecruitingObservational study
- Cincinnati Children's Hospital, Cincinnati
- UC Health, Cincinnati
Pediatric Pulmonary Hypertension Network (PPHNet) Informatics Registry
RecruitingObservational study
- Cincinnati Children's Hospital Medical Center, Cincinnati
Pulmonary Arterial Hypertension trials in other cities
- Durham, NC7 studies
- Mountain View, CA7 studies
- Kansas City, KS7 studies
- Boston, MA7 studies
- Aurora, CO7 studies
- Nashville, TN7 studies
- Philadelphia, PA6 studies
- New York City, NY5 studies
- Seattle, WA5 studies
- Dallas, TX4 studies
- Los Angeles, CA4 studies
- Houston, TX4 studies
Other studies in Cincinnati
- Non-Small Cell Lung Cancer35 studies
- Cancer (all types)27 studies
- Breast Cancer25 studies
- Heart Failure24 studies
- Colorectal Cancer21 studies
- Metastatic Cancer21 studies
- Acute Myeloid Leukemia20 studies
- Ovarian Cancer19 studies
- Obesity19 studies
- Lung Cancer19 studies
- Prostate Cancer18 studies
- Melanoma17 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.